The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy
Open accessAbstract
Autophagy is the process by which organelles and portions of the cytoplasm are degraded in lysosomes. Several different forms of autophagy are known that are distinguishable chiefly by the mode in which cargo is delivered to the lysosome for degradation. Ubiquilin was recently reported to regulate macroautophagy, the form of autophagy in which cytosolic cargo is packaged in a double-membrane structure or autophagosome that fuses with lysosomes for degradation. We confirm here using different morphological and biochemical procedures that ubiquilin is present in autophagosomes in HeLa cells and in brain and liver tissue of mouse. Coimmunoprecipitation studies indicated that ubiquilin binds the autophagosome marker LC3 in a complex and that reduction of ubiquilin expression reduces autophagosome formation, which correlates with a reduction in maturation of LC3-I to the LC3-II form of the protein. We found that ubiquilin is degraded during both macroautophagy and during chaperone-mediated autophagy (CMA), the latter of which involves the active transport of proteins into lysosomes. We discuss the implication of this degradation in mediating cross-talk between macroautophagy and CMA. Finally, we demonstrate that ubiquilin protects cells against starvation-induced cell death propagated by overexpression of mutant Alzheimer's disease PS2N141I protein and green fluorescent protein (GFP)-huntingtin exon-1 fusion protein containing 74 polyglutamines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UBQLN2 can also act as an autophagy receptor by directly interacting with LC3 in autophagosomes [219,220].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationAutophagosome formation: core machinery and adaptations
Xie, Z., & Klionsky, D. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1102 · Cited by 2,237
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Self-citationMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,334
Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., & Tashiro, Y. (1998) · Cell Structure and Function · doi:10.1247/csf.23.33 · Cited by 1,312
Boland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119
Self-citation
Research works printed but not linked: 2
- 2009, Trends in endocrinology and metabolism: TEM, 21, 142
- 2009, FEBS Letters, 584, 1399
Cited by
Sorted by citations
Items 101–200 of 225
Proteasome‐mediated proteostasis: Novel medicinal and pharmacological strategies for diseases
Mishra, R., Upadhyay, A., Prajapati, V. K., & Mishra, A. (2018) · Medicinal Research Reviews · doi:10.1002/med.21502 · Cited by 51
Whiteley, A. M., Prado, M. A., Peng, I., Abbas, A. R., Haley, B., Paulo, J. A., Reichelt, M., Katakam, A. K., Sagolla, M. S., Modrusan, Z. D., et al. (2017) · eLife · doi:10.7554/elife.26435 · Cited by 49
Structure, dynamics and functions of UBQLNs: at the crossroads of protein quality control machinery
Zheng, T., Yang, Y., & Castañeda, C. A. (2020) · Biochemical Journal · doi:10.1042/bcj20190497 · Cited by 49
Global proteomics of Ubqln2-based murine models of ALS
Whiteley, A. M., Prado, M. A., de Poot, S. A. H., Paulo, J. A., Ashton, M., Domínguez, S. L., Weber, M., Ngu, H., Szpyt, J., Jedrychowski, M. P., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015960 · Cited by 50
Self-citationAutophagy is a double‑edged sword in the therapy of colorectal cancer (Review)
Zhang, B., & Liu, L. (2021) · Oncology Letters · doi:10.3892/ol.2021.12639 · Cited by 50
Chen, X., Ebelle, D. L., Wright, B. J., Sridharan, V., Hooper, E., & Walters, K. J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.021 · Cited by 46
Li, Y., Xu, J., Chen, W., Wang, X., Zhao, Z., Li, Y., Zhang, L., Jiao, J., Yang, Q., Ding, Q., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2196876 · Cited by 47
Seki, T., Yoshino, K.-I., Tanaka, S., Dohi, E., Onji, T., Yamamoto, K., Hide, I., Paulson, H. L., Saito, N., & Sakai, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031232 · Cited by 48
Neuronal Autophagy: Regulations and Implications in Health and Disease
Liénard, C., Pintart, A., & Bomont, P. (2024) · Cells · doi:10.3390/cells13010103 · Cited by 44
SVIP Induces Localization of p97/VCP to the Plasma and Lysosomal Membranes and Regulates Autophagy
Wang, Y., Ballar, P., Zhong, Y., Zhang, X., Liu, C., Zhang, Y., Monteiro, M. J., Li, J., & Fang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024478 · Cited by 46
Self-citationInadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury
Hu, C., Tian, Y., Xu, H., Pan, B., Terpstra, E. J. M., Wu, P., Wang, H., Li, F., Liu, J., & Wang, X. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98287 · Cited by 45
Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions
Rutherford, N. J., Lewis, J. M., Clippinger, A. K., Thomas, M. A., Adamson, J. L., Cruz, P. E., Cannon, A. D., Xu, G. M., Golde, T. E., Shaw, G., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.006 · Cited by 46
The TREX1 C-terminal Region Controls Cellular Localization through Ubiquitination
Orebaugh, C. D., Fye, J. M., Harvey, S. E., Hollis, T., Wilkinson, J. C., & Perrino, F. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503391 · Cited by 43
Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
Auzmendi-Iriarte, J., & Matheu, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.630743 · Cited by 47
Identification of Genetic Modifiers of TDP-43 Neurotoxicity in Drosophila
Zhan, L., Hanson, K. A., Kim, S. H., Tare, A., & Tibbetts, R. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057214 · Cited by 43
Adegoke, O. O., Qiao, F., Liu, Y., Longley, K. R., Feng, S., & Wang, H. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170173 · Cited by 43
Mutant UBQLN2P497H in motor neurons leads to ALS-like phenotypes and defective autophagy in rats
Chen, T., Huang, B., Shi, X., Gao, L., & Huang, C. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0627-9 · Cited by 42
Ruffoli, R., Bartalucci, A., Frati, A., & Fornai, F. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00341 · Cited by 42
Safren, N., Ayadi, A. E., Chang, L., Terrillion, C. E., Gould, T. D., Boehning, D. F., & Monteiro, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087513 · Cited by 40
Self-citationKim, S. H., Zhan, L., Hanson, K. A., & Tibbetts, R. S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds321 · Cited by 37
Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS
Kim, S. H., Stiles, S., Feichtmeier, J., Ramesh, N., Zhan, L., Scalf, M., Smith, L. M., Pandey, U. B., & Tibbetts, R. S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx403 · Cited by 37
Lanuza, M. A., Just‐Borràs, L., Hurtado, E., Cilleros‐Mañé, V., Tomàs, M., García, N., & Tomàs, J. M. (2019) · Cells · doi:10.3390/cells8121578 · Cited by 41
Nuclear export of ubiquitinated proteins via the UBIN-POST system
Hirayama, S., Sugihara, M., Morito, D., Iemura, S., Natsume, T., Murata, S., & Nagata, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711017115 · Cited by 38
Coffey, R., Shi, Y., Long, M. J. C., Marr, M. T., & Hedstrom, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691584 · Cited by 36
Protein recycling pathways in neurodegenerative diseases
Fecto, F., Esengul, Y. T., & Siddique, T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt243 · Cited by 34
LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains
Satoh, J., Motohashi, N., Kino, Y., Ishida, T., Yagishita, S., Jinnai, K., Arai, N., Nakamagoe, K., Tamaoka, A., Saito, Y., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-68 · Cited by 34
Yang, S., Zhang, K. Y., Kariawasam, R., Bax, M., Fifita, J. A., Ooi, L., Yerbury, J. J., Nicholson, G. A., & Blair, I. P. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9532-1 · Cited by 35
Banduseela, V. C., Chen, Y., Kultima, H. G., Norman, H. S., Aare, S., Radell, P. J., Eriksson, L. I., Hoffman, E. P., & Larsson, L. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2012 · Cited by 36
Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases
Suresh, S., Chakravorty, A., Giridharan, M., Garimella, L., & Manjithaya, R. R. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.023 · Cited by 34
Casterton, R., Hunt, R. J., & Fanto, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.018 · Cited by 34
Kon, T., Mori, F., Tanji, K., Miki, Y., Toyoshima, Y., Yoshida, M., Sasaki, H., Kakita, A., Takahashi, H., & Wakabayashi, K. (2013) · Neuropathology · doi:10.1111/neup.12056 · Cited by 30
Port‐to‐port delivery: Mobilization of toxic sphingolipids via extracellular vesicles
Scesa, G., Moyano, A. L., Bongarzone, E. R., & Givogri, M. I. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23798 · Cited by 30
Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
Kabir, M. T., Uddin, M. S., Abdeen, A., Ashraf, G. M., Perveen, A., Hafeez, A., Bin-Jumah, M. N., & Abdel‐Daim, M. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200618114924 · Cited by 29
Sharkey, L. M., Sandoval-Pistorius, S. S., Moore, S. J., Gerson, J. E., Komlo, R., Fischer, S., Negron-Rios, K. Y., Crowley, E. V., Padrón, F., Patel, R., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105016 · Cited by 29
Lin, G., Mao, D., & Bellen, H. J. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.004 · Cited by 29
The role of lysosomes and autophagosomes in frontotemporal lobar degeneration
Bain, H. D. C., Davidson, Y. S., Robinson, A. C., Ryan, S., Rollinson, S., Richardson, A., Jones, M., Snowden, J. S., Pickering‐Brown, S., & Mann, D. M. A. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12500 · Cited by 33
Defects of Nutrient Signaling and Autophagy in Neurodegeneration
Ondaro, J., Hernández-Eguiazu, H., Garciandia-Arcelus, M., Loera‐Valencia, R., Rodríguez-Gómez, L., Jiménez-Zúñiga, A., Goikolea, J., Rodriguez‐Rodriguez, P., Ruiz‐Martínez, J., Moreno, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.836196 · Cited by 28
Ubiquilin 1 Interacts with Orai1 to Regulate Calcium Mobilization
Lee, J., Jeon, I.-S., Han, N.-E., Song, H.-J., Kim, E., Choi, J., Song, K., Lee, H., & Choi, J.-K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-2268-7 · Cited by 26
Ho, P., Hsieh, T., & Tsai, K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102441 · Cited by 28
Prognostic significance of Ubiquilin1 expression in invasive breast cancer
Wang, Y., Lu, J. M., Zhao, X., Feng, Y., Lv, S., Mu, Y., Wang, D., Fu, H., Chen, Y., & Li, Y. (2015) · Cancer Biomarkers · doi:10.3233/cbm-150503 · Cited by 24
Shared and divergent phase separation and aggregation properties of brain-expressed ubiquilins
Gerson, J. E., Linton, H., Xing, J., Sutter, A. B., Kakos, F. S., Ryou, J. H., Liggans, N., Sharkey, L. M., Safren, N., Paulson, H. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-78775-4 · Cited by 23
Lin, B. C., Phung, T. H., Higgins, N. R., Greenslade, J. E., Prado, M. A., Finley, D. J., Karbowski, M., Polster, B. M., & Monteiro, M. J. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab116 · Cited by 25
Self-citationOguro‐Ando, A., Kubota, H., Shimizu, M., Ishiura, S., & Atomi, Y. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.08.043 · Cited by 24
Ubiquilin-1 and protein quality control in Alzheimer disease
Ayadi, A. E., Stieren, E. S., Barral, J. M., & Boehning, D. F. (2013) · Prion · doi:10.4161/pri.23711 · Cited by 24
Węgrzynowicz, M., Holt, H. K., Friedman, D. B., & Bowman, A. B. (2011) · Journal of Proteome Research · doi:10.1021/pr200839d · Cited by 24
Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3
Zeng, L., Wang, B., Merillat, S. A., Minakawa, E. N., Perkins, M., Ramani, B., Tallaksen‐Greene, S. J., Costa, M. D. C., Albin, R. L., & Paulson, H. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.017 · Cited by 23
Lu, J., Florio, D. N. D., Boya, P., Maday, S., Springer, W., & Chu, C. T. (2025) · Autophagy · doi:10.1080/15548627.2025.2581217 · Cited by 22
Ubiquilin Networking in Cancers
Jantrapirom, S., Piccolo, L. L., Pruksakorn, D., Potikanond, S., & Nimlamool, W. (2020) · Cancers · doi:10.3390/cancers12061586 · Cited by 22
Zhang, X., Su, Y., Lin, H., & Yao, X. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1362 · Cited by 19
Mohan, H. M., Trzeciakiewicz, H., Pithadia, A. S., Crowley, E. V., Pacitto, R., Safren, N., Trotter, B., Zhang, C., Zhou, X., Zhang, Y., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04170-z · Cited by 16
Role of the Ubiquitin System in Stress Granule Metabolism
Tolay, N., & Buchberger, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073624 · Cited by 24
Fessel, W. J. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517698790 · Cited by 21
Satoh, J., Tabunoki, H., Ishida, T., Saito, Y., & Arima, K. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12036 · Cited by 20
The specificity of ubiquitin binding to ubiquilin-1 is regulated by sequences besides its UBA domain
Harman, C. A., & Monteiro, M. J. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.06.002 · Cited by 19
Self-citationProteostasis impairment and ALS
Lambert-Smith, I. A., Saunders, D. N., & Yerbury, J. J. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.06.001 · Cited by 19
Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2
Kim, S. H., Nichols, K. D., Anderson, E. N., Liu, Y., Ramesh, N., Jia, W., Kuerbis, C. J., Scalf, M., Smith, L. M., Pandey, U. B., et al. (2023) · eLife · doi:10.7554/elife.84382 · Cited by 19
Clinical significance of ubiquilin 1 in gastric cancer
Bao, J., Jiang, X., Zhu, X., Dai, G., Dou, R., Liu, X., Sheng, H., Liang, Z., & Yu, H. (2018) · Medicine · doi:10.1097/md.0000000000009701 · Cited by 19
Baillet, N., Krieger, S., Carnec, X., Mateo, M., Journeaux, A., Merabet, O., Caro, V., Tangy, F., Vidalain, P., & Baize, S. (2019) · Viruses · doi:10.3390/v12010049 · Cited by 17
Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?
Acker, Z. P. V., Leroy, T., & Annaert, W. G. (2024) · BioEssays · doi:10.1002/bies.202400023 · Cited by 20
Ubiquilin-1 Modulates γ-Secretase-Mediated ε-Site Cleavage in Neuronal Cells
Viswanathan, J., Haapasalo, A., Kurkinen, K. M. A., Natunen, T., Mäkinen, P. M., Bertram, L., Soininen, H. S., Tanzi, R. E., & Hiltunen, M. O. (2013) · Biochemistry · doi:10.1021/bi400138p · Cited by 16
Targeting ubiquilin-1 in Alzheimer's disease
Takalo, M., Haapasalo, A., Natunen, T., Viswanathan, J., Kurkinen, K. M. A., Tanzi, R. E., Soininen, H. S., & Hiltunen, M. O. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.791284 · Cited by 16
Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
Wang, S., Tatman, M., & Monteiro, M. J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01039-9 · Cited by 15
Self-citationSignature changes in ubiquilin expression in the R6/2 mouse model of Huntington’s disease
Safren, N., Chang, L., Dziki, K. M., & Monteiro, M. J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.12.008 · Cited by 16
Self-citationBeckers, J., & Damme, P. V. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2474796 · Cited by 19
Li, C., Liu, Z., Fu, C., Li, H., He, T., Wu, G., Sheng, Y., Shen, M., & Liu, H. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.019 · Cited by 14
UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential
Matthews, A. M., & Whiteley, A. M. (2025) · Biochemical Society Transactions · doi:10.1042/bst20253053 · Cited by 12
Houghton, O. H., Mizielinska, S., & Gómez‐Suaga, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.838402 · Cited by 12
Longobardi, A., Catania, M., Geviti, A., Salvi, E., Vecchi, E. R., Bellini, S., Saraceno, C., Nicsanu, R., Squitti, R., Binetti, G. G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021125 · Cited by 14
UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway
Chen, T., Zhang, W., Huang, B., Chen, X., & Huang, C. (2020) · Cells · doi:10.3390/cells9051205 · Cited by 12
Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD–associated UBQLN2 mutants
Strohm, L., Hu, Z., Suk, Y., Rühmkorf, A., Sternburg, E. L., Gattringer, V., Riemenschneider, H., Berutti, R., Graf, E., Weishaupt, J. H., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202101327 · Cited by 10
Aberrant protein aggregation in amyotrophic lateral sclerosis
Wang, H., & Zeng, R. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12485-z · Cited by 11
miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1)
Ding, Y., Wang, J., & Lu, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.1964892 · Cited by 11
Qiao, F., Longley, K. R., Feng, S., Schnack, S., Gao, H., Li, Y., Schlenker, E. H., & Wang, H. (2017) · Physiological Reports · doi:10.14814/phy2.13260 · Cited by 10
Yang, H., Niu, S., Guo, M., Liu, C., & Xue, Y. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.127328 · Cited by 10
Massimino, W., Andrieux, C., Biasutti, S., Davail, S., Bernadet, M.-D., Pioche, T., Ricaud, K., Gontier, K., Morisson, M., Collin, A., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.779689 · Cited by 10
Idera, A., Sharkey, L. M., Kurauchi, Y., Kadoyama, K., Paulson, H. L., Katsuki, H., & Seki, T. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.05.002 · Cited by 9
Ubiquilin 2 enhances osteosarcoma progression through resistance to hypoxic stress
Tsukamoto, S., Shimada, K., Honoki, K., Kido, A., Akahane, M., Tanaka, Y., & Konishi, N. (2015) · Oncology Reports · doi:10.3892/or.2015.3788 · Cited by 11
Ugolino, J., Dziki, K. M., Kim, A., Wu, J. J., Vogel, B. E., & Monteiro, M. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220849 · Cited by 10
Self-citationMusskopf, M. K., de Mattos, E. P., Bergink, S., & Kampinga, H. H. (2018) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0027633 · Cited by 10
Tang, M., Zeng, X., Luo, J., Quan, F., Chen, C.-Y., Li, Y., Liu, J., & Zhang, Q.-F. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112396 · Cited by 9
Владимирович, Г. К., Suslov, V. V., Александрович, Г. М., & Afonnikov, D. A. (2012) · In Silico Biology · doi:10.3233/isb-2012-0446 · Cited by 9
Mohan, H. M., Fernandez, M. G., Huang, C., Lin, R., Ryou, J. H., Seyfried, D. M., Grotewold, N., Whiteley, A. M., Barmada, S. J., Basrur, V., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu6354 · Cited by 10
Impaired 26S Proteasome Assembly Precedes Neuronal Loss in Mutant UBQLN2 Rats
Zhang, W., Huang, B., Gao, L., & Huang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094319 · Cited by 7
Ubiquilin 2 Is Not Associated with Tau Pathology
Nölle, A., van Haastert, E. S., Zwart, R., Hoozemans, J. J. M., & Scheper, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076598 · Cited by 8
Prókai-Tátrai, K., Zaman, K., Nguyen, V., Cruz, D. L. D. L., & Prókai, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091392 · Cited by 8
Ubiquilin 2: Shuttling Clients Out of Phase?
Subudhi, I., & Shorter, J. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.030 · Cited by 5
Sullivan, P. M., Zhou, X., & Hu, F. (2017) · InTech eBooks · doi:10.5772/intechopen.69371 · Cited by 6
Dihydroartemisinin is an inhibitor of trained immunity through Akt/mTOR/HIF1α signaling pathway
Gao, Y., Liu, Z., Zhang, J., Zhou, C., Zhang, J.-G., Lin, X.-Q., Yin, Q., Chen, W., & Yang, Y. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114052 · Cited by 5
Phung, T. H., Tatman, M., & Monteiro, M. J. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130284 · Cited by 5
Self-citationRole of Ubiquilin-2 in Proteostasis and Tau Aggregation in Tauopathies
Xia, Y. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0839-22.2022 · Cited by 4
Fu, Y., Li, F., Sun, X., Zhu, C., Fan, B., & Zhong, K. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109423 · Cited by 4
Yu, Y., Pang, D., Huang, J., Li, C., Cui, Y., & Shang, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-72666-8 · Cited by 4
Vargas, G., Cortes, O. H., Arias‐Muñoz, E., Hernandez-Galaz, S. F., Cerda‐Troncoso, C., Hernandez-Torres, L., González, A., Tatham, M. H., Bustamante, H. A., Retamal, C., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.743287 · Cited by 3
Roberts, J. E., Huynh, P. T., Carale, L. O., & Whiteley, A. M. (2024) · Journal of Cell Science · doi:10.1242/jcs.264105 · Cited by 3
Wang, J., Mu, X.-Y., Ma, R., Bai, X., Zhao, Z., & Wang, Y. (2023) · Journal of Oncology · doi:10.1155/2023/2339732 · Cited by 3
Protein Quality Control in Neurodegeneration and Neuroprotection
Akhter, Y., Nabi, J., Hamid, H., Tabassum, N., Pottoo, F. H., & Sharma, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch001 · Cited by 3
Yang, E. J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6773260 · Cited by 4
Overexpression of Ubiquilin4 is associated with poor prognosis in patients with cervical cancer
Wang, L., Huang, K.-J., Wang, L., & Cheng, H.-Y. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i9.2783 · Cited by 3
Selective Disposal of Insoluble Protein Aggregates
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00005-5 · Cited by 1
Guo, J., Chen, Z., Yue, H., Li, S., Sun, G., Zhang, F., Zhong, R., Lyu, J., Yang, Y., Wang, X., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04972-9 · Cited by 1
Metadata
- Authors
- Rothenberg, C., Srinivasan, D., Mah, L., Kaushik, S., Peterhoff, C. M., Ugolino, J., Fang, S., Cuervo, A. M., Nixon, R. A., & Monteiro, M. J.
- Affiliations
- University of Maryland, Baltimore (US)
- Albert Einstein College of Medicine (US)
- Nathan Kline Institute for Psychiatric Research (US)
- Corresponding author
- Monteiro, M. J.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-07
- Volume
- 19
- Issue
- 16
- Pages
- 3219-3232
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2908472
- OpenAlex
- W2107562621
- Cited by
- 225
- References
- 52
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 5 · 2022: 16 · 2021: 17 · 2020: 20 · 2019: 13 · 2018: 21 · 2017: 16 · 2016: 13 · 2015: 18 · 2014: 14 · 2013: 21 · 2012: 15
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (T32 grant)
- National Institute on Aging (AG02190, R01AG016839, AG016839, T32AG023475)
- National Institute of General Medical Sciences (GM066287, R01GM066287, GM06696)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- ubiquilin, autophagy, chaperone-mediated autophagy, macroautophagy, autophagosomes, LC3, autophagosome maturation, protein degradation, Alzheimer's disease, huntingtin exon 1, polyglutamine, HeLa cells
- MeSH terms
- Huntingtin Protein, Autophagy-Related Proteins, Animals, Autophagy, Brain, Carrier Proteins, HeLa Cells, Humans, Lysosomes, Male, Mice, Inbred C57BL, Microscopy, Fluorescence, Microtubule-Associated Proteins, Mutation, Nerve Tissue Proteins, Nuclear Proteins, Peptides, Phagosomes, Protein Binding, Transfection, Blotting, Western, Microscopy, Immunoelectron, Cell Cycle Proteins, Molecular Chaperones, Trinucleotide Repeats, RNA Interference, Adaptor Proteins, Signal Transducing, Green Fluorescent Proteins, Mice, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review